
Results
2
2 companies
PharmaEssentia
Market Cap: NT$515.3b
A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.
6446
NT$1,200.00
7D
-11.0%
1Y
180.3%
Caliway Biopharmaceuticals
Market Cap: NT$167.3b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$107.50
7D
-2.3%
1Y
-11.5%